These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18317)

  • 1. [The Cools and van Rossum theory and the pharmacology of Huntington's chorea].
    Donatelli L
    Clin Ter; 1977 Jun; 81(5):395-416. PubMed ID: 18317
    [No Abstract]   [Full Text] [Related]  

  • 2. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.
    Lal S; De la Vega C; Garelis E; Sourkes TL
    Psychiatr Neurol Neurochir; 1973; 76(2):113-7. PubMed ID: 4267059
    [No Abstract]   [Full Text] [Related]  

  • 3. Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.
    Corsini GU; Onali P; Masala C; Cianchetti C; Mangoni A; Gessa G
    Arch Neurol; 1978 Jan; 35(1):27-30. PubMed ID: 145840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
    Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R
    Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Dopamine and G.A.B.A. in Huntington's chorea.
    Lancet; 1974 Nov; 2(7889):1122-3. PubMed ID: 4139415
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent neurobiological and related pharmaco-therapeutic acquisitions in Huntington's chorea].
    Carolei A; Del Castillo G
    Clin Ter; 1979 Sep; 90(6):591-621. PubMed ID: 43793
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neuropathological and biochemical aspects and possibilities in the pharmacological treatment of Huntington's chorea].
    Carolei A; Palladini G
    Clin Ter; 1977 Sep; 82(5):495-501. PubMed ID: 144576
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical aspects of experimentally induced parkinsonism.
    Goldstein M; Anagnoste B; Battista AF; Nakatani S; Ogawa M
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():434-47. PubMed ID: 4403657
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Huntington's chorea with sulpiride.
    Knowling MR; Wrench W
    S Afr Med J; 1991 Feb; 79(3):169. PubMed ID: 1825239
    [No Abstract]   [Full Text] [Related]  

  • 11. Rational approaches to the pharmacotherapy of chorea.
    Chase TN
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():337-50. PubMed ID: 137504
    [No Abstract]   [Full Text] [Related]  

  • 12. Levodopa in Huntingtons chorea.
    Sishta SK; Templer DI
    Can Med Assoc J; 1976 May; 114(9):798-9. PubMed ID: 131644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Attempted direct etiological treatment of Huntington's chorea. Case reports].
    Majeron MA; Ambrosoli C; Armocida G; Finavera L; Quisi Q
    Minerva Med; 1980 Apr; 71(16):1213-20. PubMed ID: 6445524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and release of GABA and GABA in Huntington's chorea [proceedings].
    Iversen LL
    Psychopharmacol Bull; 1977 Jan; 13(1):30-1. PubMed ID: 138147
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract]   [Full Text] [Related]  

  • 16. Huntington's disease and HDACi: would sulpiride and valproate be of therapeutic value?
    Tremolizzo L; Rodriguez-Menendez V; DiFrancesco JC; Sala G; Galbussera A; Appollonio I; Ferrarese C
    Med Hypotheses; 2007; 69(4):964-5. PubMed ID: 17428619
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
    Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K
    Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Model of choreic movement in monkey--contribution for understanding the mechanism of chorea in Huntington's disease].
    Kanazawa I
    Jikken Dobutsu; 1990 Apr; 39(2):168-72. PubMed ID: 2141819
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of tetrabenazine for Huntington's disease-associated chorea.
    Poon LH; Kang GA; Lee AJ
    Ann Pharmacother; 2010 Jun; 44(6):1080-9. PubMed ID: 20442355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.